FDA clears TRIA's acne treatment device for OTC
This article was originally published in The Rose Sheet
Executive Summary
TRIA Beauty is planning a spring 2010 launch for its blue light device designed for home treatment of acne, after receiving over-the-counter clearance from FDA, firm announces. The device will debut on TRIABeauty.com and at select retailers. Firm says its blue light technology is 10 times more powerful than other OTC blue light devices, and that it delivers clear skin faster with shorter treatment times. TRIA cites clinical studies demonstrating the technology "cleared breakouts as quickly and effectively as professional blue light treatments." The company's home-use permanent laser hair-removal device received FDA approval in 2007; it retails for $595 (1"The Rose Sheet" Nov. 9. 2009)
You may also be interested in...
TRIA Enhances Home Hair-Removal Device, Lowers Price In Time For Holidays
TRIA Beauty has upgraded its laser hair-removal device, knocked $200 off the price and launched a multimedia marketing campaign to entice shoppers this holiday season
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.